# Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

> **NCT00601640** · PHASE2 · COMPLETED · sponsor: **University of Arizona** · enrollment: 184 (actual)

## Conditions studied

- Other Benign Neoplasm of Skin, Unspecified

## Interventions

- **DRUG:** Diclofenac Na gel
- **DRUG:** Eflornithine HCL ointment

## Key facts

- **NCT ID:** NCT00601640
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2010-02
- **Final completion:** 2014-12
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2017-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601640, "Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00601640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*